When calculating the rebate owed by manufacturers for a rebatable drug that has more than one manufacturer, we proposed to codify the policy from section 50.13 of the revised Medicare Part B Drug Inflation Rebate Guidance to multiply the total rebate amount calculated for the billing and payment code by the following quotient: (Sum of the individual manufacturer's billing units sold during the applicable calendar quarter for all NDCs of the manufacturer assigned to the billing and payment code, as reported in the ASP data submissions) divided by (Sum of all manufacturers' total billing units sold during the applicable calendar quarter for all NDCs of the Part B rebatable drug assigned to the billing and payment code, as reported in the ASP data submissions) We received public comments on this calculation approach
We stated that we anticipate that our review and analysis of reopening requests could occur over a protracted period of time during which we may be able to provide little additional information to the ACO until we have reached our decision
Unique Origin Genetic Code: Unlike most peptides, which are coded by the nuclear genome, MOTS-c is encoded by a short open reading frame (sORF) within the mitochondrial genome (mtDNA), specifically the 12S rRNA region
Presently, patients seek guidance and information on various health topics from APRNs, including medication management before, during, and after their ASD diagnosis
Age and Sex PA is more common in a temperate climate
In 2025 we believe that targeted drug delivery will become the new norm, and it will demand a change of practice
